Search - tctmd.com

Displaying 561 - 580 of 697

Sort: Relevancy | Date

News Daily News

Financial Burden of Hypertension Weighs Heavily on US Population

Todd Neale

May 30, 2018

News Daily News

One in Five ACS Patients Does Not Fill P2Y12 Inhibitor Prescription After PCI

Michael O'Riordan

May 21, 2018

News Conference News HRS 2018

‘Think Big, But Act Small’: Specialized A-fib Clinic Cuts Mortality

Todd Neale

May 18, 2018

News Conference News EAS 2018

Glucose and Beyond? Experts Debate Optimal Targets for Managing CV Risk in Diabetics

Yael L. Maxwell

May 16, 2018

News Daily News

PREDICT-1° CVD Risk Calculator, Based on Present-Day Patients, Beats ACC/AHA ‘Pooled Cohort’ Equations

Michael O'Riordan

May 10, 2018

News Daily News

FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen

Michael O'Riordan

April 25, 2018

News Daily News

New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS

Yael L. Maxwell

April 18, 2018

News Daily News

Costs of Atherosclerotic CVD Cripple Low-Income Families, Even With Insurance

Shelley Wood

April 06, 2018

News Daily News

Rates of Heart Failure After Acute MI Declining, Statewide Analysis Shows

Michael O'Riordan

April 05, 2018

News Daily News

Respiratory Syncytial Virus Linked With Cardiovascular Complications

Michael O'Riordan

April 04, 2018

News Daily News

More CV Hospitalizations Later in Life for Mothers of Babies With Heart Defects

Caitlin E. Cox

April 02, 2018

News Daily News

Varenicline Boosts Long-term Quit Rate in Post-ACS Smokers: EVITA

Caitlin E. Cox

March 26, 2018

News Features

ISCHEMIA Fracas: Amid Charges of Moving the Goalposts, Investigators Come Out Swinging

Michael O'Riordan

March 23, 2018

News Conference News ACC 2018

High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab

Michael O'Riordan

March 20, 2018

News Conference News

CANVAS Analysis Provides Heart Failure Reassurances for Canagliflozin

Michael O'Riordan

March 16, 2018

News Conference News ACC 2018

Precision Medicine Gamble Fails for CETP Inhibitors in ACCELERATE Analysis

Michael O'Riordan

March 14, 2018

News Daily News

No Increased Risk of Serious Liver Injury Seen With NOACs

Todd Neale

March 13, 2018

News Conference News ACC 2018

Perioperative MIs Bring Too Many Patients Back to the Hospital After Noncardiac Surgery

Yael L. Maxwell

March 10, 2018

News Conference News ACC 2018

ODYSSEY Delivers a Win for Alirocumab in ACS, With a Signal of Survival Benefit

Michael O'Riordan

March 10, 2018

News Conference News ACC 2018

ACC 2018, Day One: Live From Orlando! The ODYSSEY Begins

Shelley Wood

March 10, 2018

Advertisement

Financial Burden of Hypertension Weighs Heavily on US Population

One in Five ACS Patients Does Not Fill P2Y12 Inhibitor Prescription After PCI

‘Think Big, But Act Small’: Specialized A-fib Clinic Cuts Mortality

Glucose and Beyond? Experts Debate Optimal Targets for Managing CV Risk in Diabetics

PREDICT-1° CVD Risk Calculator, Based on Present-Day Patients, Beats ACC/AHA ‘Pooled Cohort’ Equations

FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen

New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS

Costs of Atherosclerotic CVD Cripple Low-Income Families, Even With Insurance

Rates of Heart Failure After Acute MI Declining, Statewide Analysis Shows

Respiratory Syncytial Virus Linked With Cardiovascular Complications

More CV Hospitalizations Later in Life for Mothers of Babies With Heart Defects

Varenicline Boosts Long-term Quit Rate in Post-ACS Smokers: EVITA

ISCHEMIA Fracas: Amid Charges of Moving the Goalposts, Investigators Come Out Swinging

High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab

CANVAS Analysis Provides Heart Failure Reassurances for Canagliflozin

Precision Medicine Gamble Fails for CETP Inhibitors in ACCELERATE Analysis

No Increased Risk of Serious Liver Injury Seen With NOACs

Perioperative MIs Bring Too Many Patients Back to the Hospital After Noncardiac Surgery

ODYSSEY Delivers a Win for Alirocumab in ACS, With a Signal of Survival Benefit

ACC 2018, Day One: Live From Orlando! The ODYSSEY Begins

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content